Fundraising FoxLifespan Vision Ventures
Venture capitalNorwalk · Pre-Seed–Series A · 3 people tracked
Find your way into Lifespan Vision Ventures
Sign up to see every warm intro you have to Lifespan Vision Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lifespan Vision Ventures team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Lifespan Vision Ventures backs founders developing therapeutics and technologies aimed at aging and age-related disease, with the goal of extending healthy lifespan (healthspan). The firm concentrates on pre-seed, seed, and Series A stages, believing early capital most shapes a company's trajectory, while being capitalized to support portfolio companies through later rounds. It emphasizes deep relationships across academia, industry, and financial markets to connect founders with the right people and accelerate timelines. Focus spans the biology of aging, therapeutic areas such as oncology, neurodegeneration and metabolic disease, and modalities including AI drug discovery, gene therapy, reprogramming technologies and small molecules.
Source: firm website, verified Oct 3, 2026.
Team · 3 people
from the firm's website
What they invest in
from 19 of 26 portfolio companiesBiotech ×19Healthtech ×11Deep Tech ×9Longevity ×9AI & Machine Learning ×7Digital Health ×2Medical Devices ×2
HQs:United States×14United Kingdom×1
Who they back
founder profiles across 12 portfolio companiesFounding team size:solo founder×42 founders×33 founders×5
Where their founders studiedfrom 14 founders with education data
Caltech ×2Columbia Engineering ×2Columbia University ×2University of California, Berkeley ×2
What their founders studiedfrom 15 founders with field-of-study data
Life Sciences ×9Engineering ×4Computer Science ×3Physics ×3Business & Management ×2
Where their founders worked beforefrom 15 founders with career history
Biotech CEO Sisterhood ×2Wyss Institute for Biologically Inspired Engineering ×2
Accelerator rootsportfolio companies that came through a program
Investments · 26 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 22019 · 15 dated
Algen Biotechnologies discovers and develops small molecule therapeutics for cancer and inflammatory diseases using CRISPR, RNAi, and machine learning to decode functional gene networks and predict drug responses.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Chun-Hao Huang(Founder)inChristine Du(Founder)inJennifer DoudnaDr. Jeff Whitten(Chief Scientific Officer)
Co-investorsCota CapitalDraper AssociatesRebel FundY CombinatorSequoia CapitalViking Global
BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development.
AI & Machine LearningBiotechDeep TechLongevity
Dr. Peterson
Co-investorsBioGenerator VenturesMissouri Technology CorporationquadraScope Venture Fund
Bolden Therapeutics is a biotechnology company developing therapeutics that promote neurogenesis—the formation of new brain cells—to treat neurological and central nervous system diseases such as Alzheimer's.
BiotechDeep TechProvidence, US
Johnny Page(Co-Founder & CEO)inAshley Webb(Scientific Founder)Justin Fallon(Scientific Founder & Chair of Scientific Advisory Board)Dr. Polsky(Executive Chairman)
Co-investorsSlater Technology FundPartners Resolute
Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders.
BiotechDigital HealthLongevitySan Francisco, US
Robin Mansukhani(CEO and Co-Founder)inAnil Bhushan(Scientific Founder)in
BoardDylan Morris(Director)in
Co-investorsage1Bold Capital PartnersCornucopian Capital ManagementCRV (Charles River Ventures)Mana VenturesOwl Capital+2 more
EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair.
BiotechHealthtechMedical DevicesNew York, US
Nina Tandon(Co-Founder, CEO)inSarindr Bhumiratana(Co-Founder)inGordana Vunjak-Novakovic(Director)Elma Hawkins(Director)
BoardRobert Langer(Director)David Zhu(Director)in
Co-investorsBeresford VenturesCatalytic Impact FoundationEMV CapitalHackensack Meridian Health Bear's DenKendall Capital PartnersMEDA Angels+3 more
Fauna Bio applies AI and computational analysis to its proprietary biobank of data from extreme mammals such as hibernating species to identify drug targets that are conserved across species including humans.
AI & Machine LearningBiotechDeep TechHealthtechEmeryville, US
Linda Goodman(Founder)inAshley(CEO)
Co-investorsage1Farvatn VentureGRIDS CapitalLifeforce CapitalMetaplanetPalo Santo VC+7 more
General Proximity develops proximity-based technologies for drug discovery and development.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
Armand Cognetta(Founder)in
Co-investorsY Combinatorage1Felicis VenturesFreemind InvestmentsModi VenturesCoughdrop Capital+2 more
Immunis Biomedical develops multi-active biologics based on stem cell-derived secretomes — cell-free therapeutics containing proteins, lipids and growth factors — aimed at treating age-related and immune-related diseases.
BiotechHealthtechLongevityIrvine, US
Gabriel Nistor(Executive Officer)
BoardTakahide Koda(Director)Daniel Kraft(Director)inHans Keirstead(Chairman of the Board)
Co-investorsBold Capital PartnersJLSquadraScope Venture FundRemiges Ventures, Inc.
Integrated Biosciences is a biotech company developing treatments and interventions for aging-related diseases using a combination of medicinal chemistry, biochemistry, aging biology, and artificial intelligence.
AI & Machine LearningBiotechLongevity
Daniel J. Anderson(Chief Scientific Officer)inSean Brown(Head of Medicinal Chemistry)inDan Whalen(Head of Biochemistry)inSatotaka Omori(Head of Aging Biology)inAlex Peysakhovich(Head of AI)in
Co-investorsSutter Hill VenturesPage One Ventures
Lift Biosciences develops Immunomodulatory Alpha Neutrophils (IMANs), off-the-shelf neutrophil-lineage cell therapies designed to kill tumor cells and restart anti-tumor immune responses in cancer patients.
BiotechHealthtech
Modulo is a biotech company focused on the neuroimmune system, developing treatments for brain and central nervous system disorders.
AI & Machine LearningBiotechDeep TechLos Altos, US
Mike Horowitz(CEO & Co-founder)Justin Ichida(Co-founder)inScott Patterson(CTO & Co-founder)inJoe Wagner(Chief Development Officer)
BoardAlda Leu Dennis(Director)inNicholas Saccomano(Director)
Co-investorsCantos VenturesHAWKTAILInitialized CapitalMana VenturesSpacecadet VenturesBioverge+2 more
Paulex Bio is developing an oral medicine aimed at regenerating beta cells to address the underlying cause of type 1 and type 2 diabetes.
BiotechDigital HealthLa Jolla, US
Sanjuan Miguel(Chief Executive Officer)in
BoardEdgardo Rayo(Director)Mohammad Hayat(Director)Francisco Leon(Director)in
Rejuvenate Bio develops gene therapy treatments aimed at the root causes of aging to address chronic, age-related conditions such as osteoarthritis, heart disease, and cancer.
BiotechHealthtechLongevitySan Diego, US
Noah Davidsohn(CSO, Co-Founder)inDaniel Oliver(CEO, Co-Founder)inGeorge Church(Co-Founder and SAB)Deborah Ascheim(Chief Medical Officer)in
Co-investorsCompanion FundConnecticut InnovationsDigitalis VenturesKendall Capital PartnersVCapitalKdT Ventures
Rejuvenation develops proprietary mRNA and lipid nanoparticle technology to safely lengthen telomeres in human cells, targeting cellular aging and diseases caused by short telomeres including pulmonary fibrosis, liver disease, and bone marrow failure.
BiotechDeep TechHealthtechLongevitySan Francisco, US
Glenn Markov(Founder)inJohn Ramunas(Founder)in
Co-investorsAsymmetry VenturesGold Dragon VenturesStartupsStartXY CombinatorAgrolimen Ventures+7 more
Remedium Bio is a biotech company developing gene therapy and biologic treatments for osteoarthritis and other rheumatology and metabolic conditions, drawing on research into cartilage regeneration and the FGF18 protein.
BiotechHealthtechLongevityBoston, US
Luppino Francesco(Executive Officer, Director)
Co-investorsUlu VenturesHKX Capital
SENISCA is a University of Exeter biotech developing RNA-based senotherapeutics that target dysregulated RNA splicing to reverse cellular senescence and treat age-related disease.
BiotechDeep TechLongevity
Lorna Harries(Founder)in
Co-investorsAPEX VenturesR42 Group
Sift Biosciences develops T-cell immunotherapies for cancer and autoimmune diseases, using an AI-driven discovery platform combined with metagenomics and high-throughput cellular screening to identify microbially derived molecules that activate memory T cells.
AI & Machine LearningBiotechHealthtechSan Carlos, US
Yue Clare Lou(Co-Founder & CEO)in
BoardKevin Barrett(Director)inAltar Munis(Director)
Co-investorsEisai Innovation, Inc.SBI HoldingsFifty YearsFREEFLOW
TECregen develops regenerative biologic therapies aimed at thymus regeneration and restoring immune function, using ligand engineering, targeted delivery, and functional screening.
BiotechHealthtechLongevity
Co-investorsBoehringer Ingelheim Venture Fund
Violet is a therapeutics company developing small molecule treatments for central nervous system diseases, using its proprietary C-to-C Engine platform to identify disease-relevant cell-to-cell interactions.
BiotechDeep TechCambridge, US
William E Yelle(Executive Officer, Director)Atsushi Usami(Director)Meredith Fisher(Executive Officer, Director)Jonathan Behr(Director)
Co-investorsDementia DiscoveryDementia Discovery FundOno Venture Investment, Inc.SV Health InvestorsUTEC
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AlgenImmunis, Inc.Marble TherapeuticsMatter BioModuloNanoticsPriveBio
Portfolio news
latest coverage across their companiesRemedium · finsmes.com · Aug 10, 2026
Rejuvenate Bio · finsmes.com · Jun 8, 2026
Frequently asked questions
- How many investments has Lifespan Vision Ventures made?
- Lifespan Vision Ventures has 26 tracked investments, including 4 dated in the last 24 months.
- What stage does Lifespan Vision Ventures invest at?
- Lifespan Vision Ventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Lifespan Vision Ventures focus on?
- Lifespan Vision Ventures focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Longevity.
- Where is Lifespan Vision Ventures located?
- Lifespan Vision Ventures is headquartered in Norwalk, US.
- Does Lifespan Vision Ventures lead rounds?
- Yes, Lifespan Vision Ventures leads investment rounds.
- Who does Lifespan Vision Ventures co-invest with?
- Lifespan Vision Ventures most often shares deals with quadraScope Venture Fund, age1, Y Combinator, among 62 tracked co-investors.
Similar investors
AlleyCorp is an early-stage investor and incubator based in New York that builds and backs companies across enterprise, consumer, healthcare, and deep tech sectors.
Two Bear Capital is a venture firm that backs founders working on breakthrough solutions to complex problems at the intersection of life sciences and technology.
.png)
Better Ventures is an early-stage venture capital firm backing mission-driven technology companies working to build a better world across climate, health, and workforce sectors.
Obvious is a venture capital firm focused on supporting founders building solutions to humanity's largest challenges across planetary health, human health, and economic health.
LongeVC is a venture capital firm backing early-stage founders in biotech and longevity, aiming to bring breakthrough science and treatments to market.